» Articles » PMID: 17445241

Neurokinin 3 Receptor Activation Potentiates the Psychomotor and Nucleus Accumbens Dopamine Response to Cocaine, but Not Its Place Conditioning Effects

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2007 Apr 21
PMID 17445241
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Neurokinin(3) receptors (NK(3)-Rs) have been implicated in psychomotor activity and reinforcement mechanisms. Recently, we showed that NK(3)-R antagonism blocked the psychostimulant properties of cocaine both in rats and in primates. Here, using in vivo microdialysis in the nucleus accumbens (NAc) of freely moving rats, we investigated the effect of the NK(3)-R agonist senktide (0.2 and 0.4 mg/kg s.c.) on the cocaine-evoked increase in dopamine. Cocaine (10 mg/kg i.p.) increased dopamine levels to 404 and 480% of baseline in the core and shell of the NAc, respectively. Pretreatment with senktide at a dose of 0.2 mg/kg potentiated this effect to 666 (core) and 869% (shell) of baseline, without having any effect on dopamine when given alone. Behavioural measurements revealed that 0.2 mg/kg senktide also potentiated the cocaine-induced increase in horizontal and vertical activity. Senktide alone induced a short-lasting increase in activity that was not accompanied by any alterations of the neurochemical parameters. In conditioned place preference (CPP) experiments, senktide pretreatment did not alter CPP induced by cocaine (5 and 10 mg/kg i.p.), and had no effect when given alone. Likewise, cocaine-conditioned locomotor activity was not affected by the NK(3)-R agonist. However, as in the microdialysis studies, cocaine-induced (5 and 10 mg/kg i.p.) hyperactivity was potentiated by senktide, and there was evidence for a facilitation of sensitization to the hyperlocomotor effects of cocaine by senktide. These data provide evidence that NK(3)-Rs are involved in the control of the hyperlocomotor and NAc DA response to cocaine, but not in cocaine-induced CPP.

Citing Articles

Neurokinin receptors in drug and alcohol addiction.

Schank J Brain Res. 2020; 1734:146729.

PMID: 32067964 PMC: 7138066. DOI: 10.1016/j.brainres.2020.146729.


Prenatal Exposure to Methamphetamine: Up-Regulation of Brain Receptor Genes.

Zoubkova H, Tomaskova A, Nohejlova K, Cerna M, Slamberova R Front Neurosci. 2019; 13:771.

PMID: 31417344 PMC: 6686742. DOI: 10.3389/fnins.2019.00771.


Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.

de Souza Silva M, Lenz B, Rotter A, Biermann T, Peters O, Ramirez A Proc Natl Acad Sci U S A. 2013; 110(37):15097-102.

PMID: 23983264 PMC: 3773732. DOI: 10.1073/pnas.1306884110.


A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schonig K Brain. 2013; 136(Pt 2):412-32.

PMID: 23413261 PMC: 3572936. DOI: 10.1093/brain/aws358.


Error awareness and the insula: links to neurological and psychiatric diseases.

Klein T, Ullsperger M, Danielmeier C Front Hum Neurosci. 2013; 7:14.

PMID: 23382714 PMC: 3563042. DOI: 10.3389/fnhum.2013.00014.